1006300-02-2 Usage
Uses
Used in Pharmaceutical Industry:
(3-bromo-5-methylphenyl)(5-isopropyl-2,6-dimethoxypyrimidin-4-yl)methanone could be used as a pharmaceutical compound for [application reason] due to its complex structure and the presence of various functional groups that may interact with biological targets.
Used in Chemical Research:
In the field of chemical research, (3-bromo-5-methylphenyl)(5-isopropyl-2,6-dimethoxypyrimidin-4-yl)methanone may serve as a starting material or intermediate for the synthesis of other complex organic molecules, taking advantage of its reactive groups for further functionalization.
Used in Material Science:
(3-bromo-5-methylphenyl)(5-isopropyl-2,6-dimethoxypyrimidin-4-yl)methanone might also find applications in material science, potentially as a component in the development of new materials with specific properties, such as those related to its electronic, optical, or mechanical characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1006300-02-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,3,0 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1006300-02:
(9*1)+(8*0)+(7*0)+(6*6)+(5*3)+(4*0)+(3*0)+(2*0)+(1*2)=62
62 % 10 = 2
So 1006300-02-2 is a valid CAS Registry Number.
1006300-02-2Relevant academic research and scientific papers
NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS
-
Page/Page column 384, (2009/03/07)
The invention is related to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, ester, and/ or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
PROCESSES FOR PREPARING HIV REVERSE TRANSCRIPTASE INHIBITORS
-
Page/Page column 13; 15, (2009/07/10)
Compounds of Formula (I): can be prepared by a multi-step process from compounds of Formula (II): wherein G is Cl, Br or I.
Novel HIV reverse transcriptase inhibitors
-
Page/Page column 35-36; 67, (2008/06/13)
The invention is related to compounds of Formula (I), (II), or (III): or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
